| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |